Discovery of ciliary G protein-coupled receptors regulating pancreatic islet insulin and glucagon secretion. 2021

Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
Baxter Laboratory, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305, USA.

Multiple G protein-coupled receptors (GPCRs) are expressed in pancreatic islet cells, but the majority have unknown functions. We observed specific GPCRs localized to primary cilia, a prominent signaling organelle, in pancreatic α and β cells. Loss of cilia disrupts β-cell endocrine function, but the molecular drivers are unknown. Using functional expression, we identified multiple GPCRs localized to cilia in mouse and human islet α and β cells, including FFAR4, PTGER4, ADRB2, KISS1R, and P2RY14. Free fatty acid receptor 4 (FFAR4) and prostaglandin E receptor 4 (PTGER4) agonists stimulate ciliary cAMP signaling and promote glucagon and insulin secretion by α- and β-cell lines and by mouse and human islets. Transport of GPCRs to primary cilia requires TULP3, whose knockdown in primary human and mouse islets relocalized ciliary FFAR4 and PTGER4 and impaired regulated glucagon or insulin secretion, without affecting ciliary structure. Our findings provide index evidence that regulated hormone secretion by islet α and β cells is controlled by ciliary GPCRs providing new targets for diabetes.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D043562 Receptors, G-Protein-Coupled The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS. G Protein Coupled Receptor,G-Protein-Coupled Receptor,G-Protein-Coupled Receptors,G Protein Coupled Receptors,Receptor, G-Protein-Coupled,Receptors, G Protein Coupled
D047908 Intracellular Signaling Peptides and Proteins Proteins and peptides that are involved in SIGNAL TRANSDUCTION within the cell. Included here are peptides and proteins that regulate the activity of TRANSCRIPTION FACTORS and cellular processes in response to signals from CELL SURFACE RECEPTORS. Intracellular signaling peptide and proteins may be part of an enzymatic signaling cascade or act through binding to and modifying the action of other signaling factors. Intracellular Signaling Peptides,Intracellular Signaling Proteins,Peptides, Intracellular Signaling,Proteins, Intracellular Signaling,Signaling Peptides, Intracellular,Signaling Proteins, Intracellular
D050417 Insulin-Secreting Cells A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN. Pancreatic beta Cells,beta Cells, Pancreatic,Pancreatic B Cells,B Cell, Pancreatic,B Cells, Pancreatic,Cell, Insulin-Secreting,Cells, Insulin-Secreting,Insulin Secreting Cells,Insulin-Secreting Cell,Pancreatic B Cell,Pancreatic beta Cell,beta Cell, Pancreatic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
May 2022, Biochimica et biophysica acta. Molecular cell research,
Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
June 2007, Endocrinology,
Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
January 2016, Methods in cell biology,
Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
June 2011, Current opinion in pharmacology,
Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
April 2003, Assay and drug development technologies,
Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
February 2019, Turkish journal of medical sciences,
Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
December 2017, Current opinion in pharmacology,
Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
March 2019, eLife,
Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
January 2022, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Chien-Ting Wu, and Keren I Hilgendorf, and Romina J Bevacqua, and Yan Hang, and Janos Demeter, and Seung K Kim, and Peter K Jackson
January 2015, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!